BBP-398
Phase 1Terminated 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Tumor
Conditions
Advanced Solid Tumor, Advanced or Metastatic Non-small Cell Lung Cancer
Trial Timeline
Oct 18, 2022 → Mar 29, 2024
NCT ID
NCT05621525About BBP-398
BBP-398 is a phase 1 stage product being developed by LianBio for Advanced Solid Tumor. The current trial status is terminated. This product is registered under clinical trial identifier NCT05621525. Target conditions include Advanced Solid Tumor, Advanced or Metastatic Non-small Cell Lung Cancer.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05621525 | Phase 1 | Terminated |
Competing Products
20 competing products in Advanced Solid Tumor